Newscrate logo

Browse the latest utica news online for free

Search results for "utica"

Citius Pharmaceuticals (CTXR) Surges 22% After Hours — Here's Why
Citius Pharmaceuticals (CTXR) Surges 22% After Hours — Here's Why

Citius Pharmaceuticals Inc. (NASDAQ:CTXR) shares jumped 22.12% in after-hours trading to $1.27 on Tuesday, following the company’s fiscal year 2025 business update and the commercial launch of its flagship oncology therapy.Check out the current price of CTXR stock here. LYMPHIR Launch Marks First... Read more

Benzinga - Dec 24
Trump, nine pharmaceutical companies strike deal to cut drug prices
Trump, nine pharmaceutical companies strike deal to cut drug prices

Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior administration officials said,... Read more

Dallas News - Dec 19
Pharmaceutical giant eyeing Denton for $280 million manufacturing plant
Pharmaceutical giant eyeing Denton for $280 million manufacturing plant

The eighth-largest pharmaceuticals company in the world, Swiss-based Novartis, is planning a $280 million manufacturing plant in Denton. Read more

Dallas News - Dec 15
The pharmaceutical industry’s frequent flyers and empty promises
The pharmaceutical industry’s frequent flyers and empty promises

Private jets owned by six of the largest U.S. drugmakers have touched down in Washington-area airports 127 times this year, while millions of Americans are struggling to afford prescription drugs, highlighting the greed of the pharmaceutical industry and the need for bipartisan reform. Read more

The Hill - Dec 13
EpiEndo Pharmaceutical's ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients
EpiEndo Pharmaceutical's ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients

ERJ Open Research article reports that Glasmacinal, a novel macrolide, was well tolerated and reduced neutrophilic inflammation in COPD patients. Read more

Globenewswire_fr - Dec 08
$100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
$100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth This Much Today

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 15 years by 6.85% on an annualized basis producing an average annual return of 18.9%. Currently, Vertex Pharmaceuticals has a market capitalization of $116.23 billion. Buying $100 In VRTX: If ...Full story available on... Read more

Benzinga - Dec 05
U.K. and U.S. reach deal for zero tariffs on British-made pharmaceuticals
U.K. and U.S. reach deal for zero tariffs on British-made pharmaceuticals

The United States and the United Kingdom have agreed on a zero-tariffs deal for medications manufactured in Britain. The NHS will pay more for drugs. Read more

Upi - Dec 01
Utica breaks ground on $2M restoration of Bialas Ski Center.
Utica breaks ground on $2M restoration of Bialas Ski Center.

Utica Mayor Michael Galime, NYS Assemblywoman Marianne Buttenschon give remarks Nov. 24 at groundbreaking of restored Bialas Ski Center, Conkling Park Read more

Yahoo! News - Nov 25
Here's How Much $1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
Here's How Much $1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 14.96% on an annualized basis producing an average annual return of 23.64%. Currently, Regeneron Pharmaceuticals has a market capitalization of $79.69 billion. Buying $1000 In REGN: If ...Full story avai... Read more

Benzinga - Nov 24
Utica police offers advice after reports of porch pirates
Utica police offers advice after reports of porch pirates

With the advent of internet shopping, package theft has never been easier as porch pirate season starts to kick off. Read more

Yahoo! News - Nov 24